DIANA JENNINGS: Open Payments
NPI 1144731571 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 93 payments from 17 companies in 2025. Trend: 2023 $1,615 · 2024 $2,129 · 2025 $2,235
Food & beverage: $2,155Education: $80
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 9 | $441 |
| Janssen Biotech, Inc. | 16 | $281 |
| Novartis Pharmaceuticals Corporation | 14 | $245 |
| Lilly USA, LLC | 6 | $217 |
| Galderma Laboratories, L.P. | 8 | $213 |
| ABBVIE INC. | 13 | $212 |
| PFIZER INC. | 6 | $120 |
| UCB, Inc. | 3 | $100 |
| LEO Pharma Inc. | 4 | $95 |
| GENZYME CORPORATION | 2 | $81 |
Products named: Zoryve, TREMFYA, EBGLYSS, NEMLUVIO, COSENTYX, SKYRIZI, Bimzelx, DUPIXENT.
Industry payments across FL — which companies pay providers there.
